BSE Live
Apr 17, 11:24Prev. Close
160.65
Open Price
160.00
Bid Price (Qty.)
160.00 (17)
Offer Price (Qty.)
162.90 (77)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Cash Flow of Makers Laboratories (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 13.41 | -3.92 | -0.84 | 15.69 | 0.00 | |
| Net CashFlow From Operating Activities | -4.08 | 0.84 | -8.62 | 8.50 | 0.00 | |
| Net Cash Used In Investing Activities | 19.75 | -6.89 | 1.25 | -11.79 | 0.00 | |
| Net Cash Used From Financing Activities | -15.84 | 5.74 | 5.78 | 0.33 | 0.00 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -0.17 | -0.31 | -1.59 | -2.96 | 0.00 | |
| Cash And Cash Equivalents Begin of Year | 0.41 | 0.72 | 2.31 | 5.27 | 0.00 | |
| Cash And Cash Equivalents End Of Year | 0.24 | 0.41 | 0.72 | 2.31 | 0.00 |
20.02.2026
Makers Labs Consolidated December 2025 Net Sales at Rs 35.67 crore, up 28.81% Y-o-Y
19.02.2026
Makers Labs Standalone December 2025 Net Sales at Rs 12.70 crore, up 34.43% Y-o-Y
14.11.2025
Makers Labs Consolidated September 2025 Net Sales at Rs 34.17 crore, up 15.58% Y-o-Y
12.11.2025
Makers Labs Standalone September 2025 Net Sales at Rs 12.64 crore, up 9.89% Y-o-Y
20.02.2026
Makers Labs Consolidated December 2025 Net Sales at Rs 35.67 crore, up 28.81% Y-o-Y
19.02.2026
Makers Labs Standalone December 2025 Net Sales at Rs 12.70 crore, up 34.43% Y-o-Y
14.11.2025
Makers Labs Consolidated September 2025 Net Sales at Rs 34.17 crore, up 15.58% Y-o-Y
12.11.2025
Makers Labs Standalone September 2025 Net Sales at Rs 12.64 crore, up 9.89% Y-o-Y
13.04.2026
13.04.2026
10.04.2026
09.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth